A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.

BACKGROUND Thimerosal is an ethylmercury-containing preservative in vaccines. Toxicokinetic studies have shown children received doses of mercury from thimerosal-containing vaccines (TCVs) that were in excess of safety guidelines. Previously, an ecological study showing a significant association between TCVs and neurodevelopmental disorders (NDs) in the US was published in this journal. MATERIAL/METHODS A two phased population-based epidemiological study was undertaken. Phase one evaluated reported NDs to the Vaccine Adverse Event Reporting System (VAERS) following thimerosal-containing Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccines in comparison to thimerosal-free DTaP vaccines administered from 1997 through 2001. Phase two evaluated the automated Vaccine Safety Datalink (VSD) for cumulative exposures to mercury from TCVs at 1-, 2-, 3-, and 6-months-of-age for infants born from 1992 through 1997 and the eventual risk of developing NDs. RESULTS Phase one showed significantly increased risks for autism, speech disorders, mental retardation, personality disorders, and thinking abnormalities reported to VAERS following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. Phase two showed significant associations between cumulative exposures to thimerosal and the following types of NDs: unspecified developmental delay, tics, attention deficit disorder (ADD), language delay, speech delay, and neurodevelopmental delays in general. CONCLUSIONS This study showed that exposure to mercury from TCVs administered in the US was a consistent significant risk factor for the development of NDs. It is clear from these data and other recent publications linking TCVs with NDs that additional ND research should be undertaken in the context of evaluating mercury-associated exposures and thimerosal-free vaccines should be made available.

[1]  R. Gerlai,et al.  Autism: a large unmet medical need and a complex research problem , 2003, Physiology & Behavior.

[2]  D. Geier,et al.  The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. , 2005, Medical hypotheses.

[3]  S Bernard,et al.  The role of mercury in the pathogenesis of autism , 2002, Molecular Psychiatry.

[4]  M Hornig,et al.  Neurotoxic effects of postnatal thimerosal are mouse strain dependent , 2004, Molecular Psychiatry.

[5]  J. Mason,et al.  Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.

[6]  F..  Reproductive and Developmental Toxicity of Metals , 1983, Springer US.

[7]  W. Spitzer,et al.  Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), The Changing Prevalence of Autism in California , 2003, Journal of autism and developmental disorders.

[8]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[9]  David A Geier,et al.  A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[10]  D. Geier,et al.  A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. , 2004, Clinical and experimental rheumatology.

[11]  A. Gasset,et al.  Teratogenicities of ophthalmic drugs. II. Teratogenicities and tissue accumulation of thimerosal. , 1975, Archives of ophthalmology.

[12]  D. Brown,et al.  Predicted mercury concentrations in hair from infant immunizations: cause for concern. , 2001, Neurotoxicology.

[13]  John W. Glasser,et al.  The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. , 2001, The New England journal of medicine.

[14]  Robert T. Chen,et al.  Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines , 2003, Expert review of vaccines.

[15]  J. Heron,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[16]  Roberta F. White,et al.  Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. , 1998, Environmental research.

[17]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[18]  Bernard Rimland,et al.  Association between thimerosal-containing vaccine and autism. , 2003, JAMA.

[19]  D. Geier,et al.  Neurodevelopmental Disorders Following Thimerosal-Containing Childhood Immunizations: A Follow-Up Analysis , 2004, International journal of toxicology.

[20]  D. Geier,et al.  A review of the Vaccine Adverse Event Reporting System database , 2004, Expert opinion on pharmacotherapy.

[21]  S Bernard,et al.  Autism: a novel form of mercury poisoning. , 2001, Medical hypotheses.

[22]  M. Salive,et al.  An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. , 1999, Vaccine.

[23]  W. Slikker,et al.  Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. , 2005, Neurotoxicology.

[24]  S. Rosenthal,et al.  The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. , 1996, Archives of pediatrics & adolescent medicine.

[25]  R. Reading.  Thimerosal and the occurrence of autism: negative ecological evidence from Danish population‐based data , 2004 .

[26]  Robert T. Chen,et al.  Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. , 2003, Vaccine.

[27]  L. Ball,et al.  An assessment of thimerosal use in childhood vaccines. , 2001, Pediatrics.

[28]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[29]  P. Decouflé,et al.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. , 2001, Pediatrics.

[30]  Mark R. Geier,et al.  A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders , 2003 .

[31]  F. Destefano,et al.  Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. , 1999, American journal of epidemiology.

[32]  Diane Simpson,et al.  Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. , 2003, American journal of preventive medicine.

[33]  Nick Andrews,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[34]  C. Rice,et al.  Prevalence of autism in a US metropolitan area. , 2003, JAMA.

[35]  M. Geier.  Thimerosal in Childhood Vaccines, Neurodevelopment Disorders, and Heart Disease in the United States Finally, we analyzed data from the US , 2003 .

[36]  Mark F Blaxill,et al.  Thimerosal and autism? A plausible hypothesis that should not be dismissed. , 2004, Medical Hypotheses.

[37]  David A Geier,et al.  Neurodevelopmental Disorders after Thimerosal-Containing Vaccines: A Brief Communication , 2003, Experimental biology and medicine.

[38]  J. Parry.  An evaluation of the use of in vitro tubulin polymerisation, fungal and wheat assays to detect the activity of potential chemical aneugens. , 1993, Mutation research.

[39]  Mark F Blaxill,et al.  What's Going on? The Question of Time Trends in Autism , 2004, Public health reports.

[40]  V. Didenko,et al.  Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  N. Syed,et al.  Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury , 2001, Neuroreport.

[42]  R. Gerlai,et al.  Autism: a target of pharmacotherapies? , 2004, Drug discovery today.

[43]  Mark F Blaxill,et al.  Reduced Levels of Mercury in First Baby Haircuts of Autistic Children , 2003, International journal of toxicology.

[44]  S. Albertini,et al.  Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay. , 1991, Mutagenesis.

[45]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[46]  Robert T. Chen,et al.  An Errant Critique That Misses the Mark , 1996 .

[47]  T. Verstraeten.  Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. , 2004, Pediatrics.

[48]  M. Wallin,et al.  Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. , 1993, Mutation research.

[49]  David A Geier,et al.  An assessment of the impact of thimerosal on childhood neurodevelopmental disorders , 2003, Pediatric rehabilitation.